Rezultati pretrage - Peyman Eshghi

Evaluation of Aryoseven Safety (Recombinant Activated Factor VII) in Patients with Bleeding Disorders (An Observational Post-Marketing Surveillance Study) od Gholamreza Toogeh, Hassan Abolghasemi, Peyman Eshghi, Mohammadreza Managhchi, Mohammadreza Shaverdi-niasari, Katayoon Karimi, Samin Roostaei, Neda Emran, Alireza Abdollahi

Connect to this object online.

Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients od Hassan Abolghasemi, MD, Yunes Panahi, PhD, Minoo. Ahmadinejad, MD, Gholamreza Toogeh, MD, Mehran Karimi, MD, Aziz Eghbali, MD, Nargess Bigom Mirbehbahani, MD, Bighan Keikhaei Dehdezi, MD, Zahra Badiee, MD, Hamid Hoorfar, MD, Peyman Eshghi, MD, Nader Maghsoudi, PhD, Amirhossein Sahebkar, PhD, Mohammad Gholami- Fesharaki, PhD

Connect to this object online.